This statistic shows the revenue of the industry “manufacture of basic pharmaceutical products and pharmaceutical preparations“ in Cyprus from 2012 to 2018, with a forecast to 2025. It is projected that the revenue of manufacture of basic pharmaceutical products and pharmaceutical preparations in Cyprus will amount to approximately 317.53 million U.S. Dollars by 2025.
Industry revenue of “manufacture of basic pharmaceutical products“ in Cyprus from 2012 to 2025 (in million U.S. Dollars)
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Market value of non-prescription drugs in Italy 2001-2022
- Premium Statistic Pharmaceutical companies - revenue from top 3 products 2022
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
- Premium Statistic Revenue of China's Yunnan Baiyao Group 2022, by source
- Premium Statistic Operating costs of China's Yunnan Baiyao Group 2022, by type
- Premium Statistic Revenue of China's Yunnan Baiyao Group 2018-2022, by region
- Premium Statistic Annual revenue of Yunnan Baiyao Group 2012-2022
- Premium Statistic Gross profit of Yunnan Baiyao Group China 2011-2022
- Premium Statistic Total assets of Yunnan Baiyao Group China 2012-2022
- Premium Statistic R&D spending of China's Yunnan Baiyao Group 2014-2022
Selected statistics
10
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
Related statistics
10
- Premium Statistic Industry revenue of “manufacture of basic pharmaceutical products“ in Germany 2012-2025
- Premium Statistic Industry revenue of “manufacture of basic pharmaceutical products“ in Greece 2012-2025
- Premium Statistic Industry revenue of “manufacture of basic pharmaceutical products“ in Denmark 2012-2025
- Premium Statistic Industry revenue of “manufacture of basic pharmaceutical products“ in Switzerland 2012-2025
- Premium Statistic Industry revenue of “manufacture of basic pharmaceutical products“ in Poland 2012-2025
- Premium Statistic Industry revenue of “manufacture of basic pharmaceutical products“ in the Netherlands 2012-2025
- Premium Statistic Industry revenue of “manufacture of basic pharmaceutical products“ in Austria 2012-2025
- Premium Statistic Industry revenue of “manufacture of basic pharmaceutical products“ in Belgium 2012-2025
- Premium Statistic Industry revenue of “manufacture of basic pharmaceutical products“ in Sweden 2012-2025
- Premium Statistic Industry revenue of “manufacture of basic pharmaceutical products“ in Italy 2012-2025
Further related statistics
9
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Number of employees at Sinopharm 2011-2022
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Sinopharm 2010-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Key figures on established biotech centers worldwide 2012-2016
- Expenditure worldwide on diabetes by market 2013-2018
- R&D expenditure in U.S. biotechnology 2009-2010 by type
Further Content: You might find this interesting as well
Statistics
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Number of employees at Sinopharm 2011-2022
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Sinopharm 2010-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Key figures on established biotech centers worldwide 2012-2016
- Expenditure worldwide on diabetes by market 2013-2018
- R&D expenditure in U.S. biotechnology 2009-2010 by type
Eurostat. (July 29, 2021). Industry revenue of “manufacture of basic pharmaceutical products“ in Cyprus from 2012 to 2025 (in million U.S. Dollars) [Graph]. In Statista. Retrieved June 05, 2024, from https://www.statista.com/forecasts/908053/manufacture-of-basic-pharmaceutical-products-revenue-in-cyprus
Eurostat. "Industry revenue of “manufacture of basic pharmaceutical products“ in Cyprus from 2012 to 2025 (in million U.S. Dollars)." Chart. July 29, 2021. Statista. Accessed June 05, 2024. https://www.statista.com/forecasts/908053/manufacture-of-basic-pharmaceutical-products-revenue-in-cyprus
Eurostat. (2021). Industry revenue of “manufacture of basic pharmaceutical products“ in Cyprus from 2012 to 2025 (in million U.S. Dollars). Statista. Statista Inc.. Accessed: June 05, 2024. https://www.statista.com/forecasts/908053/manufacture-of-basic-pharmaceutical-products-revenue-in-cyprus
Eurostat. "Industry Revenue of “manufacture of Basic Pharmaceutical Products“ in Cyprus from 2012 to 2025 (in Million U.S. Dollars)." Statista, Statista Inc., 29 Jul 2021, https://www.statista.com/forecasts/908053/manufacture-of-basic-pharmaceutical-products-revenue-in-cyprus
Eurostat, Industry revenue of “manufacture of basic pharmaceutical products“ in Cyprus from 2012 to 2025 (in million U.S. Dollars) Statista, https://www.statista.com/forecasts/908053/manufacture-of-basic-pharmaceutical-products-revenue-in-cyprus (last visited June 05, 2024)
Industry revenue of “manufacture of basic pharmaceutical products“ in Cyprus from 2012 to 2025 (in million U.S. Dollars) [Graph], Eurostat, July 29, 2021. [Online]. Available: https://www.statista.com/forecasts/908053/manufacture-of-basic-pharmaceutical-products-revenue-in-cyprus